>>> US Research Calls I

Research Calls I
  • Upgrades
    • C.H. Robinson (CHRW) upgraded to Outperform from Peer Perform at Wolfe Research, tgt $112
    • Cintas (CTAS) upgraded to Equal Weight from Underweight at Wells Fargo, tgt $221
    • Hasbro (HAS) upgraded to Buy from Neutral at Goldman, tgt $85
    • Hyatt (H) upgraded to Strong Buy from Market Perform at Raymond James, tgt $165
    • Ionis Pharmaceuticals (IONS) upgraded to Overweight from Equal Weight at Barclays, tgt $57
    • Melco Resorts (MLCO) upgraded to Overweight from Neutral at JPMorgan, tgt $9.50
    • Nike (NKE) upgraded to Buy from Hold at Argus, tgt $85
    • Oshkosh (OSK) upgraded to Buy from Neutral at Goldman, tgt $131
    • Ovintiv (OVV) upgraded to Buy from Neutral at Goldman, tgt $51
    • Ryder (R) upgraded to Outperform from Peer Perform at Wolfe Research, tgt $159
    • Solventum (SOLV) upgraded to Buy from Hold at Argus, tgt $90
  • Downgrades
    • Avino Silver & Gold Mines (ASM) downgraded to Neutral from Buy at Roth Capital, tgt $3.50
    • Coterra Energy (CTRA) downgraded to Neutral from Buy at Goldman, tgt $31
    • Hecla Mining (HL) downgraded to Neutral from Buy at Roth Capital, tgt $6
    • INmune Bio (INMB) downgraded to Underperform from Outperform at Scotiabank, tgt $0.60
    • INmune Bio (INMB) downgraded to Neutral from Buy at BTIG
    • Lineage (LINE) downgraded to Sector Weight from Overweight at KeyBanc
    • Southern Copper (SCCO) downgraded to Neutral from Buy at UBS, tgt $105
    • Sweetgreen (SG) downgraded to Hold from Buy at TD Cowen, tgt $19
    • Textron (TXT) downgraded to Neutral from Buy at Goldman, tgt $85
  • Others
    • Alpha Metallurgical (AMR) initiated with a Hold at Jefferies, tgt $110
    • Amrize (AMRZ) initiated with a Neutral at Goldman, tgt $57
    • Black Diamond Therapeutics (BDTX) resumed with an Outperform at Raymond James, tgt $11
    • CarMax (KMX) assumed with an Overweight at Morgan Stanley, tgt $80
    • Carrier Global (CARR) initiated with a Hold at Melius Research, tgt $90
    • Celcuity (CELC) resumed with a Buy at Stifel, tgt $30
    • CleanSpark (CLSK) initiated with a Buy at B. Riley Securities, tgt $16
    • Compass Therapeutics (CMPX) resumed with an Outperform at Raymond James, tgt $9
    • CoreCivic (CXW) initiated with a Buy at Texas Capital, tgt $28
    • Crexendo (CXDO) initiated with a Buy at Needham, tgt $8
    • First Busey (BUSE) initiated with an Overweight at Piper Sandler, tgt $30
    • Gen Digital (GEN) resumed with an Outperform at Evercore ISI, tgt $35
    • Genius Sports (GENI) initiated with a Buy at Truist, tgt $14
    • Geo Group (GEO) initiated with a Buy at Texas Capital, tgt $30
    • Hippo (HIPO) initiated with a Buy at B. Riley Securities, tgt $35
    • Kite Realty (KRG) initiated with a Neutral at UBS, tgt $24
    • Krystal Biotech (KRYS) initiated with a Buy at Clear Street, tgt $190
    • MasTec (MTZ) initiated with a Buy at Roth Capital, tgt $210
    • New Fortress Energy (NFE) initiated with a Buy at Compass Point, tgt $8.50
    • Omada Health (OMDA) initiated with a Buy at Canaccord, tgt $27
    • Omada Health (OMDA) initiated with a Buy at Goldman, tgt $29
    • Omada Health (OMDA) initiated with a Buy at Needham, tgt $23
    • Omada Health (OMDA) initiated with an Overweight at Barclays, tgt $21
    • Omada Health (OMDA) initiated with an Overweight at JPMorgan, tgt $19
    • Omada Health (OMDA) initiated with an Overweight at Morgan Stanley, tgt $25
    • Porch Group (PRCH) initiated with a Buy at B. Riley Securities, tgt $15
    • QXO (QXO) initiated with a Buy at Truist, tgt $30
    • Rollins (ROL) initiated with an Overweight at Piper Sandler, tgt $70
    • Sportradar (SRAD) initiated with a Buy at Truist, tgt $33
    • Summit Therapeutics (SMMT) initiated with a Buy at UBS, tgt $30
    • Verona Pharma (VRNA) initiated with an Outperform at Wolfe Research, tgt $170